Circulating MicroRNAs as Biomarkers for the Early Diagnosis of Lung Cancer and Its Differentiation from Tuberculosis

Background: The differential diagnosis of tuberculosis (TB) and lung cancer (LC) is often challenging due to similar clinicopathological presentations when bacterial shedding is negative, which can lead to delays in treatment. In this study, we tested the potential of plasma-circulating microRNAs (m...

Full description

Saved in:
Bibliographic Details
Main Authors: Yeldar Ashirbekov, Nazgul Khamitova, Kantemir Satken, Arman Abaildayev, Ilya Pinskiy, Askar Yeleussizov, Laura Yegenova, Anargul Kairanbayeva, Danara Kadirshe, Gulzhakhan Utegenova, Nurlan Jainakbayev, Kamalidin Sharipov
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/14/23/2684
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846124398979842048
author Yeldar Ashirbekov
Nazgul Khamitova
Kantemir Satken
Arman Abaildayev
Ilya Pinskiy
Askar Yeleussizov
Laura Yegenova
Anargul Kairanbayeva
Danara Kadirshe
Gulzhakhan Utegenova
Nurlan Jainakbayev
Kamalidin Sharipov
author_facet Yeldar Ashirbekov
Nazgul Khamitova
Kantemir Satken
Arman Abaildayev
Ilya Pinskiy
Askar Yeleussizov
Laura Yegenova
Anargul Kairanbayeva
Danara Kadirshe
Gulzhakhan Utegenova
Nurlan Jainakbayev
Kamalidin Sharipov
author_sort Yeldar Ashirbekov
collection DOAJ
description Background: The differential diagnosis of tuberculosis (TB) and lung cancer (LC) is often challenging due to similar clinicopathological presentations when bacterial shedding is negative, which can lead to delays in treatment. In this study, we tested the potential of plasma-circulating microRNAs (miRNAs) for the early and differential diagnosis of TB and LC. Methods: We conducted a two-phase study: profiling 188 miRNAs in pooled plasma samples and validating 14 selected miRNAs in individual plasma samples from 68 LC patients, 38 pulmonary TB patients, and 41 healthy controls. Results: Twelve miRNAs were significantly elevated in LC patients compared to controls and TB patients, while two miRNAs were significantly elevated in TB patients compared to controls. ROC analysis demonstrated that miR-130b-3p, miR-1-3p, miR-423-5p, and miR-200a-3p had good discriminatory ability to distinguish LC patients (including those with stage I tumours) from healthy individuals and miR-130b-3p, miR-423-5p, miR-15b-5p, and miR-18b-5p effectively distinguished LC patients (including those with stage I tumours) from TB patients. Additionally, miR-18b-5p showed good discriminatory ability between SCLC and NSCLC patients. Conclusions: Circulating miRNAs hold strong potential for the early detection of LC and for distinguishing LC from TB.
format Article
id doaj-art-dc8180e0aa7a46bcae2268ed1c679e70
institution Kabale University
issn 2075-4418
language English
publishDate 2024-11-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj-art-dc8180e0aa7a46bcae2268ed1c679e702024-12-13T16:24:39ZengMDPI AGDiagnostics2075-44182024-11-011423268410.3390/diagnostics14232684Circulating MicroRNAs as Biomarkers for the Early Diagnosis of Lung Cancer and Its Differentiation from TuberculosisYeldar Ashirbekov0Nazgul Khamitova1Kantemir Satken2Arman Abaildayev3Ilya Pinskiy4Askar Yeleussizov5Laura Yegenova6Anargul Kairanbayeva7Danara Kadirshe8Gulzhakhan Utegenova9Nurlan Jainakbayev10Kamalidin Sharipov11Aitkhozhin Institute of Molecular Biology and Biochemistry, Almaty 050012, KazakhstanAitkhozhin Institute of Molecular Biology and Biochemistry, Almaty 050012, KazakhstanAitkhozhin Institute of Molecular Biology and Biochemistry, Almaty 050012, KazakhstanAitkhozhin Institute of Molecular Biology and Biochemistry, Almaty 050012, KazakhstanAl-Farabi Kazakh National University, Almaty 050040, KazakhstanKazakh Institute of Oncology and Radiology, Almaty 050012, KazakhstanNational Scientific Center of Phthisiopulmonology, Almaty 050010, KazakhstanNational Scientific Center of Phthisiopulmonology, Almaty 050010, KazakhstanAitkhozhin Institute of Molecular Biology and Biochemistry, Almaty 050012, KazakhstanAitkhozhin Institute of Molecular Biology and Biochemistry, Almaty 050012, KazakhstanKazakh-Russian Medical University, Almaty 050004, KazakhstanAitkhozhin Institute of Molecular Biology and Biochemistry, Almaty 050012, KazakhstanBackground: The differential diagnosis of tuberculosis (TB) and lung cancer (LC) is often challenging due to similar clinicopathological presentations when bacterial shedding is negative, which can lead to delays in treatment. In this study, we tested the potential of plasma-circulating microRNAs (miRNAs) for the early and differential diagnosis of TB and LC. Methods: We conducted a two-phase study: profiling 188 miRNAs in pooled plasma samples and validating 14 selected miRNAs in individual plasma samples from 68 LC patients, 38 pulmonary TB patients, and 41 healthy controls. Results: Twelve miRNAs were significantly elevated in LC patients compared to controls and TB patients, while two miRNAs were significantly elevated in TB patients compared to controls. ROC analysis demonstrated that miR-130b-3p, miR-1-3p, miR-423-5p, and miR-200a-3p had good discriminatory ability to distinguish LC patients (including those with stage I tumours) from healthy individuals and miR-130b-3p, miR-423-5p, miR-15b-5p, and miR-18b-5p effectively distinguished LC patients (including those with stage I tumours) from TB patients. Additionally, miR-18b-5p showed good discriminatory ability between SCLC and NSCLC patients. Conclusions: Circulating miRNAs hold strong potential for the early detection of LC and for distinguishing LC from TB.https://www.mdpi.com/2075-4418/14/23/2684lung cancertuberculosisdifferential diagnosismicroRNA
spellingShingle Yeldar Ashirbekov
Nazgul Khamitova
Kantemir Satken
Arman Abaildayev
Ilya Pinskiy
Askar Yeleussizov
Laura Yegenova
Anargul Kairanbayeva
Danara Kadirshe
Gulzhakhan Utegenova
Nurlan Jainakbayev
Kamalidin Sharipov
Circulating MicroRNAs as Biomarkers for the Early Diagnosis of Lung Cancer and Its Differentiation from Tuberculosis
Diagnostics
lung cancer
tuberculosis
differential diagnosis
microRNA
title Circulating MicroRNAs as Biomarkers for the Early Diagnosis of Lung Cancer and Its Differentiation from Tuberculosis
title_full Circulating MicroRNAs as Biomarkers for the Early Diagnosis of Lung Cancer and Its Differentiation from Tuberculosis
title_fullStr Circulating MicroRNAs as Biomarkers for the Early Diagnosis of Lung Cancer and Its Differentiation from Tuberculosis
title_full_unstemmed Circulating MicroRNAs as Biomarkers for the Early Diagnosis of Lung Cancer and Its Differentiation from Tuberculosis
title_short Circulating MicroRNAs as Biomarkers for the Early Diagnosis of Lung Cancer and Its Differentiation from Tuberculosis
title_sort circulating micrornas as biomarkers for the early diagnosis of lung cancer and its differentiation from tuberculosis
topic lung cancer
tuberculosis
differential diagnosis
microRNA
url https://www.mdpi.com/2075-4418/14/23/2684
work_keys_str_mv AT yeldarashirbekov circulatingmicrornasasbiomarkersfortheearlydiagnosisoflungcanceranditsdifferentiationfromtuberculosis
AT nazgulkhamitova circulatingmicrornasasbiomarkersfortheearlydiagnosisoflungcanceranditsdifferentiationfromtuberculosis
AT kantemirsatken circulatingmicrornasasbiomarkersfortheearlydiagnosisoflungcanceranditsdifferentiationfromtuberculosis
AT armanabaildayev circulatingmicrornasasbiomarkersfortheearlydiagnosisoflungcanceranditsdifferentiationfromtuberculosis
AT ilyapinskiy circulatingmicrornasasbiomarkersfortheearlydiagnosisoflungcanceranditsdifferentiationfromtuberculosis
AT askaryeleussizov circulatingmicrornasasbiomarkersfortheearlydiagnosisoflungcanceranditsdifferentiationfromtuberculosis
AT laurayegenova circulatingmicrornasasbiomarkersfortheearlydiagnosisoflungcanceranditsdifferentiationfromtuberculosis
AT anargulkairanbayeva circulatingmicrornasasbiomarkersfortheearlydiagnosisoflungcanceranditsdifferentiationfromtuberculosis
AT danarakadirshe circulatingmicrornasasbiomarkersfortheearlydiagnosisoflungcanceranditsdifferentiationfromtuberculosis
AT gulzhakhanutegenova circulatingmicrornasasbiomarkersfortheearlydiagnosisoflungcanceranditsdifferentiationfromtuberculosis
AT nurlanjainakbayev circulatingmicrornasasbiomarkersfortheearlydiagnosisoflungcanceranditsdifferentiationfromtuberculosis
AT kamalidinsharipov circulatingmicrornasasbiomarkersfortheearlydiagnosisoflungcanceranditsdifferentiationfromtuberculosis